Jiahua Lu

盧家驊
CE No. AFT829 Active

This page summarises the Hong Kong Securities and Futures Commission (SFC) public register record for Jiahua Lu (盧家驊), a licensed Responsible Officer with CE reference AFT829. Currently licensed at 1 firm(s): Epigen Group (Hong Kong) Limited. Active regulated activities: Type 4 - Advising on securities; Type 9 - Asset management. This person has 22.1 years of SFC licence history. Total licence records on file: 15.

Information

LinkedIn:
Email:

Licence history

FirmRoleRegulated activityFromTo
Epigen Group (Hong Kong) Limited RO Type 4 - Advising on securities 2022-12-30 present
Epigen Group (Hong Kong) Limited RO Type 9 - Asset management 2022-12-30 present
Epigen Group (Hong Kong) Limited Rep Type 4 - Advising on securities 2022-08-01 2022-12-30
Epigen Group (Hong Kong) Limited Rep Type 9 - Asset management 2022-08-01 2022-12-30
Lux Aeterna Capital Limited
恒昱資本有限公司
Rep Type 4 - Advising on securities 2021-08-20 2022-07-31
Lux Aeterna Capital Limited
恒昱資本有限公司
Rep Type 9 - Asset management 2021-08-20 2022-07-31
Epigen Group (Hong Kong) Limited RO Type 4 - Advising on securities 2019-01-02 2021-08-19
Epigen Group (Hong Kong) Limited RO Type 9 - Asset management 2018-08-01 2021-08-19
Epigen Group (Hong Kong) Limited Rep Type 9 - Asset management 2018-05-17 2018-08-01
Goldman Sachs (Asia) L.L.C.
高盛(亞洲)有限責任公司
Rep Type 1 - Dealing in securities 2006-09-04 2017-02-25
Goldman Sachs (Asia) L.L.C.
高盛(亞洲)有限責任公司
Rep Type 4 - Advising on securities 2006-09-04 2017-02-25
Morgan Stanley Asia Limited
摩根士丹利亞洲有限公司
Rep Type 1 - Dealing in securities Pre-2003 2006-08-24
Morgan Stanley Asia Limited
摩根士丹利亞洲有限公司
Rep Type 4 - Advising on securities Pre-2003 2006-08-24
Morgan Stanley Asia Limited
摩根士丹利亞洲有限公司
Rep Type 6 - Advising on corporate finance Pre-2003 2004-02-11
Morgan Stanley Asia Limited
摩根士丹利亞洲有限公司
Rep Type 7 - Providing automated trading services Pre-2003 2004-02-11

Worked alongside

The 16 closest colleagues, strongest tie first — individuals licensed at the same firm as Jiahua Lu during overlapping periods. Ranked by how long they overlapped and how similar their regulated activities were, with shared time at a smaller firm weighted more than at a large one. See the detailed formula.

NameShared firmOverlap
Sang Park Epigen Group (Hong Kong) Limited 2018–present
Shiyu Jin Epigen Group (Hong Kong) Limited 2020–present
Frederic David Levy Epigen Group (Hong Kong) Limited 2021–present
Zhiyu Zhang Epigen Group (Hong Kong) Limited 2020–2023
Wen Chen Epigen Group (Hong Kong) Limited 2022–2025
Ziyu Zhou Epigen Group (Hong Kong) Limited 2020–2021
Michael Sai Cheong Lo Epigen Group (Hong Kong) Limited 2018–2020
Siyuan Liu Lux Aeterna Capital Limited 2021–2022
Yiu Kei Chan Lux Aeterna Capital Limited 2021–2022
Yuchao Ding Lux Aeterna Capital Limited 2021–2022
Yin Huang Lux Aeterna Capital Limited 2021–2022
Kim Kuan Francis Tan Lux Aeterna Capital Limited 2021–2022
Duruo Li Lux Aeterna Capital Limited 2021–2022
Yuhan Peng Lux Aeterna Capital Limited 2021–2022
Winne Wing Sze Wong Epigen Group (Hong Kong) Limited 2021
Sef Yuan Chin Lux Aeterna Capital Limited 2021
Explore the interactive colleague network →

Related